Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2018 - Integrated Care
Download Issue
Share
Up Front
Publisher's Corner
Embracing Integrated Care for Improved Patient Outcomes
By Patrick M. Schmidt
Features
Update on Diabetes
By
Jim Trageser
Growing Old with HIV
By
Trudie Mitschang
The Misdiagnosis Dilemma
By
Meredith Whitmore
Expanding Uses of IVIG
By
Ilana Jacqueline
BioTrends Watch
Washington Report
HHS Proposed Significant Cuts to Medicare Payments for 340B Drugs
Senate Passes CHRONIC Care Act of 2017
Congress Passes Bills Extending CHIP Funding
New Rules Narrow ACA’ s Contraception Mandate
NIH Grants $9 Million to Children’s Hospital Los Angeles for SCID Research
Reimbursement FAQs
Revisiting Billing for Expensive Drug Waste
Industry News
New Drug Approved by FDA to Treat Acute Myelogenous Leukemia
FDA Approves First Subcutaneous Therapy to Treat HAE
CSL Behring ’s Privigen Now Approved to Treat CIDP
CSL Behring Awards LEAD Grants to Support Patient Rights
FDA Approves Mavyret to Treat Adults with Chronic Hepatitis C
Clinical Trial of Universal Flu Vaccine Is a Success
Study Shows Impact of Age and Pre-Existing Influenza Immune Responses in Older and Younger Adults
Study Shows a Positive Mood Could Boost Effectiveness of Flu Vaccine
FDA Approves and CDC Recommends Shingrix Vaccine to Prevent Shingles
Kedrion Biopharma and Kamada Receive FDA Approval for KEDRAB
Cutting-Edge Pediatric Cancer Therapy Approved by FDA
BioFocus
Industry Insight
Replacement Therapy for Hereditary Angioedema: Innovations Define a New Standard of Care
By Keith Berman, MPH, MBA
Patient Profile
HIV in Older Adults: A Patient's Perspective
By Trudie Mitschang
Physician Profile
HIV in Older Adults: A Scientist's Perspective
By Trudie Mitschang
BioSources
BioResearch
Subcutaneous Prophylaxis with Bispecific Monoclonal Antibody Reduces Bleeding Rate in Hemophilia A and Inhibitors
Subcutaneous Immunoglobulin Well-Tolerated and Effective in Mild to Moderate Exacerbations of Myasthenia Gravis